Teleflex (NYSE:TFX) Given “Hold” Rating at Truist Financial

Teleflex (NYSE:TFX)‘s stock had its “hold” rating restated by research analysts at Truist Financial in a report released on Monday,Benzinga reports. They currently have a $143.00 price objective on the medical technology company’s stock, up from their previous price objective of $135.00. Truist Financial’s price target indicates a potential upside of 9.87% from the company’s current price.

TFX has been the subject of several other research reports. Raymond James Financial restated an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a research report on Friday. Zacks Research upgraded shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Needham & Company LLC raised their price objective on Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Wells Fargo & Company lifted their price objective on Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research report on Friday. Finally, Wall Street Zen cut Teleflex from a “hold” rating to a “sell” rating in a report on Saturday. Three equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Teleflex presently has an average rating of “Hold” and a consensus target price of $144.00.

Teleflex Stock Down 2.2%

NYSE TFX traded down $2.90 on Monday, hitting $130.16. 235,032 shares of the stock were exchanged, compared to its average volume of 962,029. Teleflex has a fifty-two week low of $100.18 and a fifty-two week high of $139.67. The company has a 50-day moving average price of $119.44 and a 200-day moving average price of $116.73. The company has a market cap of $5.76 billion, a PE ratio of -5.71, a PEG ratio of 0.96 and a beta of 0.82. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. During the same quarter in the prior year, the company posted $1.44 earnings per share. Teleflex’s revenue for the quarter was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Sell-side analysts anticipate that Teleflex will post 6.75 EPS for the current fiscal year.

Hedge Funds Weigh In On Teleflex

Institutional investors and hedge funds have recently bought and sold shares of the stock. PNC Financial Services Group Inc. grew its position in Teleflex by 11.3% in the first quarter. PNC Financial Services Group Inc. now owns 17,346 shares of the medical technology company’s stock valued at $2,075,000 after acquiring an additional 1,759 shares in the last quarter. Heartland Advisors Inc. boosted its stake in shares of Teleflex by 107.8% in the first quarter. Heartland Advisors Inc. now owns 215,998 shares of the medical technology company’s stock valued at $25,836,000 after purchasing an additional 112,071 shares during the period. Bessemer Group Inc. grew its holdings in Teleflex by 30.5% during the 1st quarter. Bessemer Group Inc. now owns 47,798 shares of the medical technology company’s stock valued at $5,718,000 after purchasing an additional 11,180 shares in the last quarter. Illinois Municipal Retirement Fund increased its stake in Teleflex by 17.1% during the 1st quarter. Illinois Municipal Retirement Fund now owns 24,596 shares of the medical technology company’s stock worth $2,942,000 after buying an additional 3,591 shares during the period. Finally, Principal Financial Group Inc. lifted its holdings in Teleflex by 2.0% in the 1st quarter. Principal Financial Group Inc. now owns 214,193 shares of the medical technology company’s stock worth $25,620,000 after buying an additional 4,214 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.